RxDoctor Payments Data

Dean Yamaguchi, MD

Vascular Surgery · Greenville, NCNPI 1316016397

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $9,860 of the $12,724 with a category attached, or 77.5%. W. L. Gore & Associates, Inc. accounts for 77.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $8,431 and has fallen 79.8% since, to $1,700 in 2025.

$12,724in general payments, 2019–2025

Across 40 payments — averaging $318.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$10K
  • Cook Incorporated$2K
  • Cook Medical LLC$979
  • Boston Scientific$126
  • Bolton Medical Inc$120
  • Endologix LLC$68
  • plus $88 from 5 others
$3,388in research payments, 2019–2025

Across 3 payments — averaging $1129.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$3K

What the payments were for

  • Speaking & faculty fees$9,86077%
  • Travel & lodging$1,1949%
  • Food & beverage$1,67013%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,724 in reported general payments places this provider in the 75th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$371,428
Medicare patients
810
Services billed
2,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$60,663
ClopidogrelClopidogrel Bisulfate85$937
Cilostazol31$463
Atorvastatin Calcium33$351
Rosuvastatin Calcium25$223
Gabapentin15$168
Simvastatin12$86
Oxycodone Hcl12$56

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →